Kwok Pang, COO, Autolomous, London, UK, comments on Autolomous’ recent strategic partnership with Vineti, which aims to deliver supply chain management solutions in the cell and gene therapy (CGT) space by creating a seamless end-to-end CGT delivery process. Mr Pang explains that integrating the chain of identity (CoI) and chain of custody (CoC) will allow any issues to be identified and resolved during the manufacturing process, which will result in an increased transparency and improve the exchange of information to and from stakeholders. This interview took place at Advanced Therapies Week 2022.